FDA clears Intelivation Technologies new Hammerdesis™ Interphalangeal Fusion System
Intelivation Technologies, an innovative medical device company with a cutting-edge orthopedic portfolio announced today that it has received clearance from the Food and Drug Administration for its Hammerdesis™ Interphalangeal Fusion System.
Hammerdesis™ allows surgeons to correct hammertoe deformities and degenerative issues in patients by simply affixing a distinctively designed implant on the patient's toe joint. This one-of-a-kind operation benefits both surgeons and patients by saving surgeons significant intraoperative time and yielding cost savings for patients in the ambulatory surgery setting.
Dr. David Murphy, DPM FACFAS remarked, "Hammerdesis™ provides patients with a more reliable, and a more consistent option to fix hammertoe issues. My surgeon colleagues and I are excited to use this novel system, and I am looking forward to seeing our patients benefit from Hammerdesis™."
President of Intelivation, Amit Sinha, added, "There is nothing on the market today like the Hammerdesis™ procedure. This is a truly disruptive technology in a crowded area. Our product development and sales teams are looking forward to being a part of this market transformation that will make a major impact for surgeons and their patients for many years to come. We are currently preparing for our launch and post-market clinical data points to share with the orthopedic and podiatric communities."
Intelivation will be exhibiting this exciting product and others at the annual ACFAS Meeting, being held February 1-4, 2024 in Tampa, Florida.

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!